A detailed history of Altium Capital Management LP transactions in Vericel Corp stock. As of the latest transaction made, Altium Capital Management LP holds 68,000 shares of VCEL stock, worth $3.84 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
68,000
Holding current value
$3.84 Million
% of portfolio
1.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.25 - $53.56 $2.87 Million - $3.64 Million
68,000 New
68,000 $2.87 Million
Q3 2022

Nov 14, 2022

BUY
$22.62 - $32.54 $1.81 Million - $2.6 Million
80,000 New
80,000 $1.86 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.